Monkeypox is a rare disease caused by infection with the monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus in the family Poxviridae. The Orthopoxvirus genus also includes variola virus (which causes smallpox), vaccinia virus (used in the smallpox vaccine), and cowpox virus. Monkeypox is not related to chickenpox.
The World Health Organization reports that as of June 15, more than 2,100 people in 42 countries have been diagnosed with monkeypox, almost all in the past two months. As of June 17, the CDC reported 24 confirmed cases of monkeypox is in California, US. Although the CDC reports that the threat to the general U.S. population is considered low, it is important for health care providers worldwide to have a preparedness plan.
Anitoa's Monkeypox detection solution
This portable solution includes one of a family small foot-print real time PCR instruments called the Maverick qPCR, with an extraction-free multiplex PCR reagent that tests OPXV/MPXV gene-targets in the skin lesion sample from patients suspected of infection with Monkeypox. Our Monkeypox test is designed to be carried out on-site, near patient, thus avoiding the need to transport patient samples to central labs for testing.
Our Maverick line of multiplex real time PCR devices are lab-accurate, fast, portable and calibration-free. They can operate on battery power (including car battery) and takes up very little bench space. Maverick qPCR instruments are built on our proprietary CMOS biosensor technology. They have been used widely for on-site testing of food, environment samples and agriculture products due to its rugged all solid-state design, small form factor, and lower operation cost.
The Monkeypox detection solution is part of an ongoing program at Anitoa to develop tests that will help combat a series of neglected tropical diseases in low-resource settings. These tests currently include IVDR tests for Dengue, Yellow Fever, and Malaria.
Professional Portable qPCR System Manufacturer
Anitoa is a professional R&D and manufacturing company of molecular diagnostic qPCR instruments and reagents, with independent intellectual property rights of core chip technology, optical technology, rapid heating, microfluidic control and supporting reagents and other patented technologies, so that the instruments developed by Anitoa are characterized by quick and easy small instruments, allowing the development of expensive and complex large PCR instruments into truly portable POCT products.